Receptor Biologix's Acquisition

Receptor Biologix was acquired by Symphogen on January 07, 2009.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on the development and commercialization of a newly discovered class of protein therapeutics called Intron Fusion Proteins (IFP) to treat…

Articles about Receptor Biologix's Acquisition: